Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Owing to the position of the mutation in the mdx52 mutant, these mice also lack Dp260, which might account for the observed altered visual processing (Barboni et al., 2021).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Barboni et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Single-cell transcriptome sequencing: recent advances and remaining challenges
Liu, S., & Trapnell, C. (2016) · F1000Research · doi:10.12688/f1000research.7223.1 · Cited by 230
Research works printed but not linked: 58
- Adiconis, 2018, Comprehensive comparative analysis of 5′-end RNA-sequencing methods, Nat. Methods, 15, 505, 10.1038/s41592-018-0014-2 · DOI
- Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
- Aranmolate, 2017, Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy, BMC Neurosci., 18, 63, 10.1186/s12868-017-0381-0 · DOI
- Barboni, 2013, ON and OFF electroretinography and contrast sensitivity in Duchenne muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 54, 3195, 10.1167/iovs.13-11700 · DOI
- Barboni, 2016, Dystrophin is required for proper functioning of luminance and red-Green cone opponent mechanisms in the human retina, Invest. Ophthalmol. Vis. Sci., 57, 3581, 10.1167/iovs.16-19287 · doi:10.1167/iovs.16-19287
- Barboni, 2020, Rescue of Defective Electroretinographic Responses in Dp71-null mice with AAV-mediated Reexpression of Dp71, Invest. Ophthalmol. Vis. Sci., 61, 11, 10.1167/iovs.61.2.11 · DOI · Paper page
- Bladen, 2015, The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations, Hum. Mutat., 36, 395, 10.1002/humu.22758 · DOI · Paper page
- Blank, 1999, Dystrophin and beta-dystroglycan in photoreceptor terminals from normal and mdx3Cv mouse retinae, Eur. J. Neurosci., 11, 2121, 10.1046/j.1460-9568.1999.00636.x · DOI
- Bucher, 2019, The long dystrophin gene product Dp427 modulates retinal function and vascular morphology in response to age and retinal ischemia, Neurochem. Int., 104489
- Catalani, 2020, Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy, Cell. Mol. Life Sci.
- Choi, 2020, Single-cell RNA sequencing and its combination with protein and DNA analyses, Cells, 9, 10.3390/cells9051130 · DOI
- Claudepierre, 1999, Differential distribution of dystrophins in rat retina, Invest. Ophthalmol. Vis. Sci., 40, 1520
- Collin, 2020, Mouse models of inherited retinal degeneration with photoreceptor cell loss, Cells, 9
- Costa, 2011, Psychophysical measurements of luminance and chromatic spatial and temporal contrast sensitivity in Duchenne muscular dystrophy, Psychology & Neurosci., 4, 67, 10.3922/j.psns.2011.1.008 · doi:10.3922/j.psns.2011.1.008
- Cox, 1993, New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin, Nat. Genet., 4, 87, 10.1038/ng0593-87 · DOI · Paper page
- Daoud, 2008, Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS One, 4
- De Becker, 1994, Correlation between electroretinogram findings and molecular analysis in the Duchenne muscular dystrophy phenotype, Br. J. Ophthalmol., 78, 719, 10.1136/bjo.78.9.719 · doi:10.1136/bjo.78.9.719
- Desguerre, 2009, Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS One, 4, 10.1371/journal.pone.0004347 · DOI · Paper page
- D’Souza, 1995, A novel dystrophin isoform is required for normal retinal electrophysiology, Hum. Mol. Genet., 4, 837, 10.1093/hmg/4.5.837 · DOI · Paper page
- Girlanda, 1997, Extra-muscle involvement in dystrophinopathies: an electroretinography and evoked potential study, J. Neurol. Sci., 146, 127, 10.1016/S0022-510X(96)00292-4 · doi:10.1016/s0022-510x(96)00292-4
- Harazny, 2009, Electrophysiological deficits in the retina of the DBA/2J mouse, Doc. Ophthalmol., 119, 181, 10.1007/s10633-009-9194-5 · DOI
- Hauser, 1996, Progress towards gene therapy for Duchenne muscular dystrophy, J. Endocrinol., 149, 373, 10.1677/joe.0.1490373 · doi:10.1677/joe.0.1490373
- Hestand, 2010, Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies, Nucleic Acids Res., 38, 10.1093/nar/gkq602 · DOI
- Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 · DOI · Paper page
- Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum. Mol. Genet., 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
- Ino-ue, 1997, Genotype and electroretinal heterogeneity in Duchenne muscular dystrophy, Exp. Eye Res., 65, 861, 10.1006/exer.1997.0389 · DOI
- Jensen, 1995, Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X linked incomplete congenital stationary night blindness, J. Med. Genet., 32, 348, 10.1136/jmg.32.5.348 · DOI
- Juan-Mateu, 2015, DMD mutations in 576 Dystrophinopathy families: a step forward in genotype-phenotype correlations, PLoS One, 10, 10.1371/journal.pone.0135189 · DOI
- Kameya, 1997, Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina, Hum. Mol. Genet., 6, 2195, 10.1093/hmg/6.13.2195 · DOI
- Koenig, 1987, Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, 50, 509, 10.1016/0092-8674(87)90504-6 · DOI · Paper page
- Kremers, 2018, Measuring retinal function in the mouse, Methods Mol. Biol., 1753, 27, 10.1007/978-1-4939-7720-8_2 · doi:10.1007/978-1-4939-7720-8_2
- Kretschmer, 2013, OMR-arena: automated measurement and stimulation system to determine mouse visual thresholds based on optomotor responses, PLoS One, 8, 10.1371/journal.pone.0078058 · DOI
- Kretschmer, 2015, A system to measure the optokinetic and Optomotor response in mice, J. Neurosci. Methods, 256, 91, 10.1016/j.jneumeth.2015.08.007 · DOI
- Li, 2008, Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein, Am. J. Pathol., 172, 1332, 10.2353/ajpath.2008.071042 · DOI
- Miyatake, 2018, Exon skipping therapy using Phosphorodiamidate Morpholino oligomers in the mdx52 mouse model of Duchenne muscular dystrophy, Methods Mol. Biol., 1687, 123, 10.1007/978-1-4939-7374-3_9 · DOI
- Mizobe, 2018, In vivo evaluation of single-exon and multiexon skipping in mdx52 mice, Methods Mol. Biol., 1828, 275, 10.1007/978-1-4939-8651-4_17 · doi:10.1007/978-1-4939-8651-4_17
- Morris, 1995, Apo-dystrophins (Dp140 and Dp71) and dystrophin splicing isoforms in developing brain, Biochem. Biophys. Res. Commun., 215, 361, 10.1006/bbrc.1995.2474 · DOI
- Pardue, 2014, Mouse b-wave mutants, Doc. Ophthalmol., 128, 77, 10.1007/s10633-013-9424-8 · DOI
- Pascual Pascual, 1998, Electroretinogram in Duchenne/Becker muscular dystrophy, Pediatr. Neurol., 18, 315, 10.1016/S0887-8994(97)00208-7 · doi:10.1016/s0887-8994(97)00208-7
- Perronnet, 2010, Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies, J. Biomed. Biotechnol., 2010, 849426
- Pilgram, 2010, The roles of the dystrophin-associated glycoprotein complex at the synapse, Mol. Neurobiol., 41, 1, 10.1007/s12035-009-8089-5 · DOI
- Pillers, 1995, mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 36, 462
- Pillers, 1999, Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations, Hum. Genet., 105, 2, 10.1007/s004399900111 · doi:10.1007/s004399900111
- Pillers, 1999, Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants, Mol. Genet. Metab., 66, 100, 10.1006/mgme.1998.2784 · DOI
- Regus-Leidig, 2014, Photoreceptor degeneration in two mouse models for congenital stationary night blindness type 2, PLoS One, 9, 10.1371/journal.pone.0086769 · doi:10.1371/journal.pone.0086769
- Ricotti, 2016, Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system, Eur. J. Hum. Genet., 24, 562, 10.1038/ejhg.2015.135 · DOI
- Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev. Med. Child Neurol., 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
- Rodius, 1997, Dystrophins in developing retina: Dp260 expression correlates with synaptic maturation, Neuroreport, 8, 2383, 10.1097/00001756-199707070-00056 · DOI
- Sigesmund, 1994, Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy, Ophthalmology, 101, 856, 10.1016/S0161-6420(13)31249-4 · DOI
- Snow, 2013, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci. Biobehav. Rev., 37, 743, 10.1016/j.neubiorev.2013.03.016 · DOI · Paper page
- Tadayoni, 2012, Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene, Mol. Neurobiol., 45, 43, 10.1007/s12035-011-8218-9 · DOI
- Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS One, 5, 10.1371/journal.pone.0008803 · DOI · Paper page
- Tremblay, 1994, Duchenne muscular dystrophy: negative scotopic bright-flash electroretinogram but not congenital stationary night blindness, Can. J. Ophthalmol., 29, 274
- Tsai, 2016, Asymmetrical functional deficits of ON and OFF retinal processing in the mdx3Cv mouse model of Duchenne muscular dystrophy, Invest. Ophthalmol. Vis. Sci., 57, 5788, 10.1167/iovs.16-19432 · doi:10.1167/iovs.16-19432
- Vaillend, 1999, Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins, Neuromuscul. Disord., 9, 296, 10.1016/S0960-8966(99)00029-2 · DOI · Paper page
- Wachtmeister, 1978, The oscillatory potentials of the mudpuppy retina, Invest. Ophthalmol. Vis. Sci., 17, 1176
- Waite, 2009, The neurobiology of the dystrophin-associated glycoprotein complex, Ann. Med., 41, 344, 10.1080/07853890802668522 · DOI
- Wersinger, 2011, Reevaluation of dystrophin localization in the mouse retina, Invest. Ophthalmol. Vis. Sci., 52, 7901, 10.1167/iovs.11-7519 · doi:10.1167/iovs.11-7519
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Barboni, M. T. S., Liber, A. M. P., Joachimsthaler, A., Saoudi, A., Goyenvalle, A., Rendon, A., Roger, J. E., Ventura, D. F., Kremers, J., & Vaillend, C.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 152
- Pages
- 105288
- ISSN
- 0969-9961
- Cited by
- 11
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Research Development and Innovation Office (PD134799)
- CNPq (404239/2016\u20131, 309,409/2015\u20132)
- European Cooperation in Science and Technology (CA17103)
- Deutscher Akademischer Austauschdienst (57513929)
- National Centre for Scientific Research
- Université Paris-Sud
- Hungarian Scientific Research Fund
- Association Française contre les Myopathies
- Deutscher Akademischer Austauschdienst France
- Campus France
- Tempus Public Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/26818\u20132, 2016/04538\u20133, 2019/007771)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1016/j.nbd.2021.105288
- The paper
- Barboni, M. T. S., Liber, A. M. P., Joachimsthaler, A., Saoudi, A., Goyenvalle, A., Rendon, A., Roger, J. E., Ventura, D. F., Kremers, J., & Vaillend, C. (2021). Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2021.105288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.